SNDX EPS Estimates
Syndax Pharmaceuticals, Inc.
$13.53
-$0.42(-3.01%)
37
Overall
40
Value
45
Tech
28
Quality
Market Cap
$1.21B
Volume
3.04M
52W Range
$12.99 - $25.59
Target Price
$37.25
SNDX EPS estimates: the consensus estimate for Syndax Pharmaceuticals, Inc.'s current fiscal year is -$2.03 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SNDX EPS Estimates
- EPS estimate, current quarter
- $-0.51
- EPS estimate, next quarter
- $-0.52
- EPS estimate, current year
- $-2.03
- EPS estimate, next year
- $-1.03
- EPS growth, 3-year
- -10.18%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.29 |
| 2024 | $-3.72 |
| 2023 | $-2.98 |
| 2022 | $-2.46 |
| 2021 | $0.48 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SNDX | $13.53 | -3.0% | 3.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Syndax Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW